|
BioScreening - organic compounds for screening
07.02.2007 ORGANIC CHEMISTRY, PRESENT AND FUTURE
A four-day International Symposium organised in honour of Prof. Léon Ghosez
April 10 - 13, 2007 Louvain-la-Neuve (Belgium)
There are already 300 participants!
You can still REGISTER for the symposium and if you would like to submit an abstract please send it to us at: ghosezsymposium@LDOrganisation.com
All information is available under www.ghosezsymposium.org.
SYMPOSIUM PROGRAMME
The Symposium will start on Monday April 9, 2007 for registration. The scientific program will begin on Tuesday April 10, 2007 and finish on Friday April 13, 2007. Along with the 24 invited lectures, the four-day international symposium programme will provide, during lunch time, a forum for presentation and discussion through poster sessions, which will be organised together with a commercial exhibition.
CONFIRMED SPEAKERS
Catalytic and Asymmetric Vinylogous Mukaiyama Reactions: Methodology and Synthetic Applications Dr. Jean-Marc CAMPAGNE, (ENSCM, Montpellier, France)
Novel Ligands and Reactions in Asymmetric Catalysis
Dr. Juan Carlos CARRETERO, (UNIVERSIDAD AUTONOMA de MADRID, Madrid, Spain)
Selective Reactions and their Use in the Synthesis of Biologically Active Natural Products
Prof. Janine COSSY, (ESPCI, Paris, France)
Fluorous Mixture Synthesis Approaches to Natural Product Stereoisomer Libraries
Prof. Dennis P. CURRAN, (UNIVERSITY of PITTSBURGH, Pittsburgh, United States)
Organic Nanochemistry
Prof. François DIEDERICH, (ETH-ZURICH, Zürich, Switzerland)
Studies in Natural Products Synthesis
Prof. David A. EVANS, (HARVARD UNIVERSITY, CAMBRIDGE, United States)
New Chemistry from an Old-timer!
Prof. Léon GHOSEZ, (UCL, Louvain-la-Neuve, Belgium)
Radical Chemistry with Amino Acids and Peptides
Prof. Bernd GIESE, (UNIVERSITAT BASEL, Basel, Switzerland)
Discovery, Understanding and Applications of New Fluorination Processes
Dr. Véronique GOUVERNEUR, (UNIVERSITY of OXFORD, Oxford, United Kingdom)
Novel Modified Nucleobases, Nucleosides and Nucleotides: Synthesis, Biological Activity and Applications
Dr. Michal HOCEK, (IOCB, ACADEMY of SCIENCES, Prague, Czech Republic)
Protein-sized Synthetic Folded Architectures
Dr. Ivan HUC, (IECB, Pessac, France)
>From Supramolecular Chemistry to Constitutional Dynamic Chemistry
Prof. Jean-Marie LEHN, (ISIS/ULP, Strasbourg, France)
Natural Product Synthesis: a Stimulus for Discovery
Prof. Steven V. LEY, (UNIVERSITY OF CAMBRIDGE, Cambridge, United Kingdom)
Reactivity and Conformational Flexibility: a Study of Bridged Azetidinones
Prof. Jacqueline MARCHAND-BRYNAERT, (UCL, Louvain-la-Neuve, Belgium)
New Methods for the Preparation of Enantiomerically Pure Quaternary Carbon Centers
Prof. Ilan MAREK, (TECHNION-ISRAEL INSTITUTE of TECHNOLOGY, Haifa, Israel)
Efficient and Connective Synthesis of Natural Products
Prof. Istvan MARKO, (UCL, Louvain-la-Neuve, Belgium)
Total Synthesis of Bioactive Natural Products: Complex Targets-Simple Solutions
Prof. Goverdhan MEHTA, (INDIAN INSTITUTE of SCIENCE, Bangalore, India)
Fine Approach to Polymer Synthesis
Prof. Kyoko NOZAKI, (The University of Tokyo, Tokyo, Japan)
Dearomatization of Phenols – Why, How and What for?
Prof. Stéphane QUIDEAU, (UNIVERSITE de BORDEAUX 1, Talence, France)
Chiral Metal Hydrides for Asymmetric Catalysis
Prof. Olivier RIANT, (UCL, Louvain-la-Neuve, Belgium)
Rapid Formation of Molecular Complexity in Natural Product Synthesis
Prof. Erik SORENSEN, (PRINCETON UNIVERSITY, Princeton, United States)
Adventures in Peptide Synthesis and Molecular Recognition
Dr. Laurent TREMBLEAU, (UNIVERSITY of ABERDEEN, Aberdeen, United Kingdom)
Post-Translational Glycosylation: Problems and Opportunities
Prof. Chi-Huey WONG, (The SCRIPPS RESEARCH INSTITUTE, La Jolla, United States)
Catalytic Asymmetric Synthesis
Dr. Hisashi YAMAMOTO, (UNIVERSITY of CHICAGO, Chicago, United States)
A Quest for New Reactions: Some Interesting Perspectives for Organic Synthesis
Prof. Samir ZARD, (ECOLE POLYTECHNIQUE, Palaiseau, France)
Symposium Secretariat
LD ORGANISATION
+32 10 45 47 77
+32 10 45 97 19
E-mail : secretariat@LDOrganisation.com
Url : http://www.LDOrganisation.com
More bioscreening news...
07.02.2007 BIO-Europe Spring Launches in Milan
BIO-Europe Spring(TM) Launches in Milan: Business Leaders, International Biotech Industry and Italian Government Welcome New Springtime Biotech Partnering Conference
Milan, Italy, January 16, 2007: At a press conference held today at the Palazzo Marino (Sala Alessi), leaders from the Italian government, the city of Milan (with the Mayor, Miss Letizia Moratti) and luminaries from both the Italian and global biotechnology industry officially inaugurated BIO-Europe Spring. Held at the Milano Convention Center (MIC), March 5-7, 2007, BIO-Europe Spring will be the preeminent springtime partnering conference for the biotechnology industry as well as a valued counterpart to BIO-Europe, the world’s largest standalone biotechnology partnering conference.
“We are excited that the EBD Group has chosen Milan as the venue to unveil its latest biotech partnering conference, BIO-Europe Spring. When leaders of the global biotech industry gather here in March they will discover a city and region poised to become a leading center for scientific knowledge and discovery, adding to Milan’s well-known reputation as the center of the design and fashion world,” said Alessandro Sidoli, Chief Operating Officer of Axxam and Vice President of Assobiotec, the Italian Bioindustry Association, that organizes the event in partnership with EBD.
Strategic partnering is becoming an increasingly important element for companies operating in the biotechnology industry. In this highly competitive and rapidly globalizing industry, successful partnering strategies help companies gain access to new markets, funding, and identify new intellectual property for in-licensing. BIO-Europe Spring and its sister conference, BIO-Europe, use EBD Group's proprietary state-of-the-art web-based partnering software platform that enables firms from every part of the biotechnology value-chain to quickly identify, engage and enter into strategic relationships that drive their business successfully forward.
“We are proud to inaugurate our new partnering event in Milan, a city that throughout history has seen the technological innovations giving shape and meaning to the modern world,” said Carola Schropp, Founder of the leading partnering firm in the biotechnology industry, the EBD Group. “Designed as the counterpart to our flagship conference BIO-Europe, the BIO-Europe Spring event will feature the powerful combination of one-on-one partnering meetings and company presentations characteristic of all of EBD’s partnering events. It will bring together international decision-makers from all biotechnology sectors, pharmaceutical companies and financial firms.”
About EBD Group
EBD Group is the leading partnering firm for the global biotechnology industry. For over 12 years, firms in the life sciences have leveraged EBD Group’s partnering conferences, technology and services to identify business opportunities and develop strategic relationships that drive their business. EBD Group’s conferences (run in collaboration with leading industry partners and international trade associations such as BIO and Eucomed) include BIO-Europe, the world’s largest stand-alone life science partnering conference; BIO-Europe Spring; the investor conference BioEquity Europe conference (co-organized with BioCentury Publications); and the medical technology partnering conference, BioDevice Partnering. EBD’s proprietary software system also powers partnering at numerous third-party events around the world. Outside of the conference format, EBD Group’s consultants can provide hands-on operational consulting for firms seeking to in- or out license products and technologies.
EBD Group has offices in San Diego, Munich and London. For more information visit www.ebdgroup.com or www.bioeuropespring.com for conference related issues.
More bioscreening news...
09.02.2007 Tecan and VWR announce a strategic alliance for microarray products and microplate readers
Tecan and VWR International, Inc., have announced a strategic alliance to unite the strengths of each company and together provide Tecan's cutting edge microarray instruments and microplate readers to the global research market. The collaboration takes advantage of VWR's BioSciences program, which aims to provide researchers with the highest quality services and products available, whatever their application, and a comprehensive sales network - including more than 120 sales representatives worldwide and 15 BioSciences managers in Europe alone. Tecan's range of technically excellent microarray products and microplate readers offer perfect solutions for customers of the BioSciences program working in all areas of drug discovery and life science.
Siegfried Sasshofer, Head of Marketing for Tecan's Detection business unit, said, "Tecan's products and technical expertise complement the VWR's BioSciences program very well, and together we can build on our respective strengths in high end instrumentation and well-developed customer relationships. The close collaboration of both teams will benefit research communities in the US and in Europe, helping them to find the best solutions and allowing them to excel in their respective fields."
Matt Malenfant Senior VP and President Global Lab Business commented, "The BioSciences program is an investment by VWR to extend our offering of research instruments for our customers' drug discovery and development needs. Establishing a partnership with Tecan accomplishes this, offering an industry leader in laboratory automation and detection instrumentation to our broad reach of customers. Our mutual commitment to excellence will most certainly drive value for our customers."
For more information, please contact:
Tecan
Frank Siefert
Untersbergstrasse 1A, A-5082 Grödig
AUSTRIA
Tel +49 2683 988218
frank.siefert@tecan.com www.tecan.com
VWR International, Inc.
Robin Gervasoni
1310 Goshen Parkway, West Chester, PA 19380
USA
Tel 610-430-7258
robin_gervasoni@vwr.com www.vwrbiosciences.com
About Tecan
Tecan (www.tecan.com) is a leading global player in the Life Sciences supply industry specializing in the development, production, and distribution of advanced automation solutions enabling pharma and academic research, diagnostics, food and veterinary research as well as forensics. Through its REMP subsidiary (www.remp.com), Tecan is the leading supplier of compound and sample storage, management and logistics solutions. Tecan clients are pharmaceutical and biotechnology companies, university research departments and diagnostic laboratories. Founded in Switzerland in 1980, the company has manufacturing, research and development sites in both North America and Europe and maintains a sales and service network in 52 countries. In 2005, Tecan achieved sales of CHF 344.9 million (USD 275.9 Mio.; EUR 222.5 Mio.). Registered shares of Tecan Group are traded on the SWX Swiss Exchange (TK: TECN / Reuters: TECZn.S / Valor: 12100191).
About VWR International, Inc.
VWR International, Inc. is a leader in the global research laboratory industry with worldwide sales of over US $3.0 billion. VWR's business is highly diversified across a spectrum of products and services, customer groups and geography. The company offers more than 1,000,000 products and services, from more than 5,000 manufacturers, to over 250,000 customers throughout the world. VWR's primary customers work in the pharmaceutical, life science, chemical, technology, food processing and consumer product industries. Other important customers include universities and research institutes; governmental agencies; environmental testing organizations; and primary and secondary schools. VWR International affiliates operate in 20 countries and employ approximately 6,000 people. The company's mission is to deliver excellence in the distribution of scientific supplies. The VWR International Group is headquartered in West Chester, Pennsylvania.
For more information on VWR International, phone 1-800-932-5000, visit www.vwr.com, or write, VWR International, Inc., 1310 Goshen Parkway, P.O. Box 2656, West Chester, PA 19380-0906.
VWR and design are trademarks of VWR International, Inc
13.02.2007 HAMILTON aquires TekCel
The key automation solution-provider HAMILTON broadens his product portfolio and strengthens his position as market leader in laboratory automation by this acquisition.
High-tech for Cooling and Storage in research laboratories
The Boston, MA based Company TekCel designs and manufactures specialised Cooling- and Storage systems for research labs in the Biotechnology and Pharmaceutical Industry.
Sample logistics often is the key challenge in automation projects:
“Both Companies are leading in the automation technology for laboratories. The innovative technology of TekCel ideally integrates with our Liquid Handling workstations”, explains CEO Andreas Wieland, who also sees a major growth potential in the area of automated cooling systems.
By integrating TekCel systems in the product portfolio, HAMILTON emphasizes the strategic positioning as “solution-provider” for automation projects.
More bioscreening news...
28.02.2007 Biotech Industry Leaders and Exciting Start-ups to Forge Partnerships at First Ever BIO-Europe Spring Partnering Conference in Milan, March 5-7, 2007
Unique opportunity for international press to interact directly with world’s hottest biotech firms
San Diego, CA, and Munich, Germany, February 7, 2007: On Monday, March 5, the first-ever BIO-Europe Spring will open its doors at the Milano Convention Center (MIC) in Italy. The three day conference (March 5-7) promises to be exciting as deal- and decision makers from across the globe meet at the pre-eminent springtime partnering conference for the biotechnology industry.
Like its conference counterpart, BIO-Europe, which is held in the Autumn, BIO-Europe Spring will be an important focal point for companies seeking to identify new business opportunities and strike deals to drive future business. The conference, organized by EBD Group, will feature many notable industry leaders such as Rob Wills, VP of Alliance Management at Johnson & Johnson; Judith Hills, VP of Corporate and Business Development for Licensing, Europe, Japan & Asia Pacific, at Bristol-Myers Squibb; and Roger Longman, Managing Partner of Windhover Information. These and other speakers will cover a wide range of trends, issues and technologies that are shaping the industry’s future
The conference will also feature a proprietary online partnering system through which participants can set up individual meetings with potential partners—thus providing an unbeatable opportunity for direct engagement between individuals from all parts the biotechnology value chain.
EBD Group, the organizer of the BIO-Europe Spring and BIO-Europe partnering conferences, expects more than 1,000 attendees to attend the conference—which should become one of the world’s premier international partnering events for biotechnology and the life sciences. Since 1993, EBD Group’s conferences have provided annual partnering fora for networking, sharing research and innovations and striking deals. Today, the BIO-Europe conferences are the largest and most comprehensive international life science partnering events in the world.
Highlights of the BIO-Europe Spring conference sessions include:
• Rethinking the Biotech-Pharma Partnering Model: Will the whole ever be worth more than the sum of its parts?
• Next Generation Companies: With increasing competition for late-stage assets, pharmaceutical companies are taking a greater interest in earlier stage biotech companies. In keeping with this trend, some of the most exciting early-stage players of the biotech industry will make their pitches to the conference’s elite audience.
• Pink Biotech, The Convergence of White and Red Biotech: New enabling technologies are transforming the industry and cost-advantages linked to disruptive technologies are already a reality. BIO-Europe Spring will explore how the convergence of White and Red biotech will play a key role in helping both early and late-stage companies overcome industry challenges.
• Future of Mid-sized Pharma: Globalization is profoundly affecting the biotechnology industry-- and especially mid-sized pharma companies. This session explores the unique opportunities and challenges confronting mid-sized firms and discusses optimal ways to navigate the globalization trend.
Partnering System Goes Live:
The web-based conference partnering system is now live and registered attendees can access it at www.ebdgroup.com/bioeuropespring/partnering.htm . As at all EBD Group conferences, BIO-Europe Spring leverages the organizer’s proprietary state-of-the-art web-based partnering software platform. The partnering system enables all participants to quickly query a comprehensive database in order to identify and engage with many potential partners during the conference. The partnering system also allows journalists to arrange meetings and interviews in advance of the conference. Two-hundred booths will be available for one-on-one meetings. In addition, a quiet interview room in the BIO-Europe Europe press office can be booked on site. Delegates’ meeting schedules will be made available on personal log-in pages on the BIO-Europe Spring website in the days prior to the conference.
More bioscreening news...
new | june 2010 | october 2009 | may 2009 | january 2009 | october 2008 | april 2008 | january 2008 | october 2007 | september 2007 | august 2007 | march 2007 | february 2007 | january 2007 | december 2007 | september 2006 | august 2006 | july 2006 | june 2006 | may 2006 | april 2006 | march 2006 | january 2006 | november 2005 | august 2005 | july 2005 | june 2005 | may 2005 | april 2005 | march 2005 | december 2005 | november 2004 | october 2004 | september 2004 | august 2004 | july 2004 | june 2004 | may 2004 | april 2004 | march 2004 | february 2004 | january 2004 | december 2004 | november 2003 | october 2003 | september 2003 | august 2003 | july 2003 | june 2003 | may 2003
|
